On October 31, 2024, JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., priced $1,932,000 in Auto Callable Accelerated Barrier Notes linked to the performance of the S&P 500 Index, the Nasdaq-100 Index, and the Russell 2000 Index, with a maturity date of November 4, 2027. The notes, designed for investors seeking an early exit at a premium or an uncapped return of twice any appreciation of the least performing index at maturity, are unsecured and unsubordinated obligations guaranteed by JPMorgan Chase & Co. The notes offer potential automatic calls with premium payments starting November 5, 2025, if index levels meet specified values. Investors are warned of the risk of losing some or all of their principal if the indices perform poorly. The notes were settled on or about November 5, 2024, with denominations of $1,000 and integral multiples thereof. The offering, which involves risks detailed in the prospectus supplement and the prospectus addendum, has not been approved or disapproved by the SEC or any state securities commission.

On October 31, 2024, JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., priced $1,932,000 in Auto Callable Accelerated Barrier Notes linked to the performance of the S&P 500 Index, the Nasdaq-100 Index, and the Russell 2000 Index, with a maturity date of November 4, 2027. The notes, designed for investors seeking an early exit at a premium or an uncapped return of twice any appreciation of the least performing index at maturity, are unsecured and unsubordinated obligations guaranteed by JPMorgan Chase & Co. The notes offer potential automatic calls with premium payments starting November 5, 2025, if index levels meet specified values. Investors are warned of the risk of losing some or all of their principal if the indices perform poorly. The notes were settled on or about November 5, 2024, with denominations of $1,000 and integral multiples thereof. The offering, which involves risks detailed in the prospectus supplement and the prospectus addendum, has not been approved or disapproved by the SEC or any state securities commission.